Astellas is dedicated to contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. Our VISION is on the forefront of healthcare change to turn innovative science into value for patients.
Since its establishment in 2013, Astellas Innovation Management (AIM) has been playing an essential role of innovation scouting and creation of win-win partnership with external collaborators.
Located both in Cambridge, Massachusetts and Brisbane, California in the US, Cambridge in the UK, and Tsukuba in Japan in where innovative science is actively arising, AIM has robust and wide spread networks in healthcare industry, and flexible partnering structures.
We are determined to turn innovative science into value for patients with our collaboration partners.
Recent Topic: Astellas Innovation Management (AIM) has just opened of a new office in central Cambridge in the UK from April 5th, 2021. The team in Cambridge will be responsible for managing scouting activities for early-stage programs and technologies in the UK, EU, and Middle East regions.